Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [306]
News [1259]
Articles [51]
Editorials [3]
Conferences [63]
elearning [9]
Significant improvement in RFS for atezolizumab plus bevacizumab vs active...
Prof Masatoshi Kudo - Kindai University, Higashiōsaka, Japan
Significant improvement in RFS for atezolizumab plus bevacizumab vs active surveillance in HCC without compromising QoL ( Prof Masatoshi Kudo - Kindai University, Higashiōsaka, Japan )
4 Jun 2023
Tackling low-volumes of clinical trials in Africa
Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria
Tackling low-volumes of clinical trials in Africa ( Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria )
25 May 2023
The HypoAfrica study and AC3T research partnerships at NLCC
Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria
The HypoAfrica study and AC3T research partnerships at NLCC ( Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria )
17 May 2023
Achieving health equity in cancer care in the Philippines
Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The...
Achieving health equity in cancer care in the Philippines ( Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The Philippines )
10 May 2023
Durable effect of imatinib and metronomic chemotherapy with capecitabine in...
Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma ( Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan )
21 Apr 2023
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody...
Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer...
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM ( Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA )
20 Apr 2023
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic...
Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival ( Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA )
20 Apr 2023
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with...
Prof Pierce Chow - Duke-NUS Medical School, Singapore
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC ( Prof Pierce Chow - Duke-NUS Medical School, Singapore )
20 Apr 2023
Key practices for handling difficult conversations in cancer care
Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila...
Key practices for handling difficult conversations in cancer care ( Dr Madelaine Amurao-Amante - Philippine Society of Medical Oncology, Manila, Philippines )
19 Apr 2023
Choosing wisely in complementary treatment for cancer in the Philippines
Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital...
Choosing wisely in complementary treatment for cancer in the Philippines ( Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital, Dagupan City, Philippines )
19 Apr 2023
A multidisciplinary team approach to cancer care in the Philippines
Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines
A multidisciplinary team approach to cancer care in the Philippines ( Dr Arnold John Uson - Perpetual Succour Hospital of Cebu, Cebu, Philippines )
12 Apr 2023
Choosing the right serum and molecular biomarkers in the Philippines
Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines
Choosing the right serum and molecular biomarkers in the Philippines ( Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines )
12 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation